Gene therapy startup Kriya Therapeutics gets $313Mnews2025-08-15T20:58:52+00:00August 15th, 2025|Endpoints News|
Lilly gets another obesity partner in deal with Superluminal worth up to $1.3Bnews2025-08-14T12:00:30+00:00August 14th, 2025|Endpoints News|
Vedanta’s microbiome therapy fails Phase 2, company lays off 20%news2025-08-13T18:44:59+00:00August 13th, 2025|Endpoints News|
Endpoints 11 list 2025: Join Sept. 18 with George Church and this year’s top biotech startupsnews2025-08-13T18:19:12+00:00August 13th, 2025|Endpoints News|
Biotech industry goes six months without an IPOnews2025-08-13T14:26:54+00:00August 13th, 2025|Endpoints News|
VC firm Hatteras closes $200M for life sciences as it reaches 100th investmentnews2025-08-13T12:00:18+00:00August 13th, 2025|Endpoints News|
Treg biotech Abata Therapeutics closes as money runs shortnews2025-08-13T03:18:44+00:00August 13th, 2025|Endpoints News|
PureTech spins out its IPF drug as it readies for Phase 3 meeting with the FDAnews2025-08-12T15:36:17+00:00August 12th, 2025|Endpoints News|
Life sciences investor Portal Innovations eyes $100M seed fundnews2025-08-12T11:00:57+00:00August 12th, 2025|Endpoints News|
NextRNA, a long non-coding RNA startup working with Bayer, to wind downnews2025-08-11T15:40:55+00:00August 11th, 2025|Endpoints News|
